Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.

Huang T, Chen Y, Yang B, Yang J, Wahlqvist ML, Li D.

Clin Nutr. 2012 Aug;31(4):448-54. doi: 10.1016/j.clnu.2011.01.003. Epub 2012 May 29. Review.

PMID:
22652362
2.

Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.

Zhou C, Wu J, Fang S.

Clin Nutr. 2013 Apr;32(2):314. doi: 10.1016/j.clnu.2013.01.001. Epub 2013 Jan 11. No abstract available.

PMID:
23433911
3.

Reply to Fang SK--Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality.

Huang T, Li D.

Clin Nutr. 2013 Apr;32(2):315-6. doi: 10.1016/j.clnu.2013.01.002. Epub 2013 Jan 13. No abstract available.

PMID:
23391457
4.

Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.

Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL.

Eur J Intern Med. 2012 Dec;23(8):745-54. doi: 10.1016/j.ejim.2012.07.004. Epub 2012 Aug 11.

PMID:
22884409
5.

Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.

Bazzano LA, Reynolds K, Holder KN, He J.

JAMA. 2006 Dec 13;296(22):2720-6. Erratum in: JAMA. 2007 Mar 7;297(9):952.

PMID:
17164458
6.
7.

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.

Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bønaa KH, Spence JD, Nygård O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R; B-Vitamin Treatment Trialists' Collaboration.

Arch Intern Med. 2010 Oct 11;170(18):1622-31. doi: 10.1001/archinternmed.2010.348. Review.

PMID:
20937919
8.

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.

B-Vitamin Treatment Trialists' Collaboration.

Am Heart J. 2006 Feb;151(2):282-7. Review.

PMID:
16442889
9.

Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis.

Ji Y, Tan S, Xu Y, Chandra A, Shi C, Song B, Qin J, Gao Y.

Neurology. 2013 Oct 8;81(15):1298-307. doi: 10.1212/WNL.0b013e3182a823cc. Epub 2013 Sep 18.

PMID:
24049135
10.

Homocysteine-lowering trials for prevention of heart disease and stroke.

Clarke R.

Semin Vasc Med. 2005 May;5(2):215-22. Review.

PMID:
16047274
11.

Effect of B-vitamin supplementation on stroke: a meta-analysis of randomized controlled trials.

Zhang C, Chi FL, Xie TH, Zhou YH.

PLoS One. 2013 Nov 25;8(11):e81577. doi: 10.1371/journal.pone.0081577. eCollection 2013.

12.
13.

Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.

Miller ER 3rd, Juraschek S, Pastor-Barriuso R, Bazzano LA, Appel LJ, Guallar E.

Am J Cardiol. 2010 Aug 15;106(4):517-27. doi: 10.1016/j.amjcard.2010.03.064.

PMID:
20691310
14.

Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials.

Pan Y, Guo LL, Cai LL, Zhu XJ, Shu JL, Liu XL, Jin HM.

Br J Nutr. 2012 Aug;108(3):400-7. doi: 10.1017/S0007114511007033. Epub 2012 Jan 16. Review.

PMID:
22244447
15.

Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients.

Righetti M, Tommasi A, Lagona C, La Rosa L, Uccellini M, Sessa A.

Perit Dial Int. 2004 Jul-Aug;24(4):373-7.

17.

Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis.

Sudchada P, Saokaew S, Sridetch S, Incampa S, Jaiyen S, Khaithong W.

Diabetes Res Clin Pract. 2012 Oct;98(1):151-8. doi: 10.1016/j.diabres.2012.05.027. Epub 2012 Jun 22. Review.

PMID:
22727498
18.

[Vitamin treatments that lower homocysteine concentration: can they decrease cerebrovascular disease in primary prevention?].

Méndez-González J, Rodríguez-Millán E, Julve J, Blanco-Vaca F.

Rev Neurol. 2010 Feb 16-28;50(4):235-44. Review. Spanish.

19.

A systematic review and economic evaluation of statins for the prevention of coronary events.

Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, Yeo W, Payne N.

Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. Review.

20.

A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease.

Kang JH, Cook N, Manson J, Buring JE, Albert CM, Grodstein F.

Am J Clin Nutr. 2008 Dec;88(6):1602-10. doi: 10.3945/ajcn.2008.26404.

Items per page

Supplemental Content

Write to the Help Desk